Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 2
1961 2
1962 2
1963 3
1964 3
1965 1
1966 2
1967 3
1968 4
1969 4
1970 5
1971 6
1972 4
1973 1
1974 4
1975 2
1976 6
1977 2
1978 3
1979 5
1980 2
1981 2
1982 1
1983 6
1984 3
1985 9
1986 5
1987 7
1988 4
1989 3
1990 6
1991 5
1992 3
1993 7
1994 11
1995 4
1996 5
1997 11
1998 11
1999 13
2000 5
2001 3
2002 2
2003 1
2004 1
2005 3
2006 6
2007 1
2008 4
2009 2
2010 1
2011 6
2012 12
2013 11
2014 13
2015 17
2016 10
2017 12
2018 24
2019 17
2020 24
2021 20
2022 15
2023 13
2024 9
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Results by year

Filters applied: . Clear all
Page 1
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y, Miyano M, Tsukamoto S, Kogai H, Yamamoto A, Iso K, Inoue S, Yamane Y, Yabe Y, Umihara H, Taguchi J, Akagi T, Yamaguchi A, Koga M, Toshimitsu K, Hirayama T, Mukai Y, Machinaga A. Nakazawa Y, et al. Among authors: yabe y. Nat Commun. 2024 Mar 11;15(1):2192. doi: 10.1038/s41467-024-46167-1. Nat Commun. 2024. PMID: 38467634 Free PMC article.
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: yabe y. Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6. Bone. 2022. PMID: 35398293 Free article. Clinical Trial.
Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study.
Takahashi R, Chiba K, Okazaki N, Era M, Yokota K, Yabe Y, Kondo C, Fukuda T, Fukushima K, Kono M, Michikoshi Y, Yamada S, Iida T, Mitsumizo K, Sato S, Doi M, Watanabe K, Ota S, Shiraishi K, Yonekura A, Osaki M. Takahashi R, et al. Among authors: yabe y. Bone. 2024 Oct;187:117189. doi: 10.1016/j.bone.2024.117189. Epub 2024 Jul 2. Bone. 2024. PMID: 38960296 Free article. Clinical Trial.
Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles.
Suzuki N, Kanzaki M, Koide M, Izumi R, Fujita R, Takahashi T, Ogawa K, Yabe Y, Tsuchiya M, Suzuki M, Harada R, Ohno A, Ono H, Nakamura N, Ikeda K, Warita H, Osana S, Oikawa Y, Toyohara T, Abe T, Rui M, Ebihara S, Nagatomi R, Hagiwara Y, Aoki M. Suzuki N, et al. Among authors: yabe y. PLoS One. 2024 Aug 1;19(8):e0306021. doi: 10.1371/journal.pone.0306021. eCollection 2024. PLoS One. 2024. PMID: 39088432 Free PMC article.
Palau'chlor: a practical and reactive chlorinating reagent.
Rodriguez RA, Pan CM, Yabe Y, Kawamata Y, Eastgate MD, Baran PS. Rodriguez RA, et al. Among authors: yabe y. J Am Chem Soc. 2014 May 14;136(19):6908-11. doi: 10.1021/ja5031744. Epub 2014 Apr 29. J Am Chem Soc. 2014. PMID: 24758725 Free PMC article.
380 results